FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Denver Solutions, LLC DBA Leiters Health Lidocaine HCL 1% Recall

Lidocaine HCL 1% (10mg/mL), PHENYLephrine HCL 1

Denver Solutions, LLC DBA Leiters Health · Englewood, CO

Risk level
Class II
Reported by FDA
Mar 6, 2024
Recall ID
D-0363-2024
Check your lot numberHow we source this data

Summary

Denver Solutions, LLC DBA Leiters Health recalled Lidocaine HCL 1% starting Feb 20, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0363-2024 on Mar 6, 2024. Reason: Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination. Status: Ongoing.

Why it was recalled

Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.

Product description

Lidocaine HCL 1% (10mg/mL), PHENYLephrine HCL 1.5% (15mg/mL), 1 ml in a Single- Dose Vial, RX Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-090-42

Lot numbers, UPCs & expiration codes

Lot #:2331104, Exp:9-Mar-24; 2331137, Exp: 3-Mar-24; 2331196, Exp: 11-Mar-24; 2331264, Exp: 6-Apr-24; 2331282, Exp: 18-Apr-24; 2331464, Exp: 8-May-24; 2331481, Exp: 16-May-24; 2331500, Exp: 20-May-24.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0363-2024
Classification
Class II
Status
Ongoing
Recall initiated
Feb 20, 2024
FDA report date
Mar 6, 2024
Quantity
40,890 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Denver Solutions, LLC DBA Leiters Health

Original FDA data

Every field from FDA enforcement report D-0363-2024, exactly as published.

Show all FDA fields
City
Englewood
State
CO
Status
Ongoing
Country
United States
Event ID
94071
Address
13796 Compark Blvd
Code information
Lot #:2331104, Exp:9-Mar-24; 2331137, Exp: 3-Mar-24; 2331196, Exp: 11-Mar-24; 2331264, Exp: 6-Apr-24; 2331282, Exp: 18-Apr-24; 2331464, Exp: 8-May-24; 2331481, Exp: 16-May-24; 2331500, Exp: 20-May-24.
Postal code
80112-7145
Report date
Mar 6, 2024
Product type
Drugs
Recall number
D-0363-2024
Classification
Class II
Recalling firm
Denver Solutions, LLC DBA Leiters Health
Product quantity
40,890 vials
Reason for recall
Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lidocaine HCL 1% (10mg/mL), PHENYLephrine HCL 1.5% (15mg/mL), 1 ml in a Single- Dose Vial, RX Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-090-42
Distribution pattern
Nationwide in the USA
Recall initiation date
Feb 20, 2024
Initial firm notification
Letter
Center classification date
Feb 29, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0363-2024, published Mar 6, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls